IRIS
CARBONE, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 708
EU - Europa 167
AS - Asia 9
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 669
IT - Italia 95
CA - Canada 39
GB - Regno Unito 31
SE - Svezia 28
IN - India 7
DE - Germania 5
RO - Romania 3
CL - Cile 2
EU - Europa 2
CN - Cina 1
ES - Italia 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
Totale 888
Salva come PNG Salva come JPEG
Città #
Chandler 175
Lawrence 57
Princeton 57
Catanzaro 55
Ottawa 38
Ashburn 31
Wilmington 31
Chicago 30
London 30
Des Moines 17
Boardman 8
Caserta 8
Latina 6
Pune 6
Norwalk 5
Redmond 4
Hanover 3
Cosenza 2
Grottaglie 2
Naples 2
Redwood City 2
Spezzano Albanese 2
Vaslui 2
Washington 2
West Jordan 2
Aachen 1
Amsterdam 1
Ann Arbor 1
Atlanta 1
Augusta 1
Chengdu 1
Clearwater 1
Cortale 1
Fayetteville 1
Franklin Square 1
Genova 1
Giarre 1
Los Angeles 1
Milan 1
Novokuznetsk 1
Oslo 1
Potomac 1
Reggio Calabria 1
Seattle 1
Stalettì 1
Taichung 1
Totale 598
Salva come PNG Salva come JPEG
Nome #
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 38
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition. 34
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. 34
A disposable passive microfluidic device for cell culturing 31
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells 30
Mechanical stress downregulates MHC class I expression on human cancer cell membrane. 28
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors 27
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors. 26
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy. 24
HLA class I, NKG2D and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells 24
A passive microfluidic device for chemotaxis studies 24
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction 22
Recognition of autologous dendritic cells by human NK cells 21
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. 21
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts. 21
NK cells control breast cancer and related cancer stem cell hematological spread 21
Triggering of murine NK cells by CD40 and CD86 (B7-2) 19
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging. 19
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts 18
New views on natural killer cell-based immunotherapy for melanoma treatment. 18
HLA class I antigen downregulation by interleukin (IL)-10 is predominantly governed by NK-kappaB in the short term and by TAP1+2 in the long term. 18
A novel facet of tumor suppression by p53: Induction of tumor immunogenicity. 18
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells 18
Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response. 18
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18 17
Human NK Cell Subsets in Pregnancy and Disease: Toward a New Biological Complexity. 17
The Dark Side of Innate Immunity Fosters Tumor Growth and Offers New Diagnostic. 17
NK cells blur the frontier between innate and acquired immunity. 17
A novel strategy of c-myc oncogene in NK activity regulation not related to the W6/32 MHC class-I epitope 17
A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells. 17
Human natural killer cells in asymptomatic human immunodeficiency virus-1 infection 15
Autologous cytotoxicity of natural killer cells derived from HIV-infected patients 15
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice 14
Abstract Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules 14
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. 14
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization 12
Different Insight into Amphiphilic PEG-PLA Copolymers: Influence of Macromolecular Architecture on the Micelle Formation and Cellular Uptake. 12
The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real? 10
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. 10
Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level 9
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients 8
Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production. 7
Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j 7
Inhibition of ERK and proliferation in NK cell lines by soluble HLA-Ereleased from Japanese encephalitis virus infected cells 7
Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin. 7
Proliferative and cytotoxic response of human natural killer cells exposed to transporter associated with antigen-processing-deficient cells.interferon-gamma production by human natural killer effectors. 7
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation. 7
NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system 6
Natural killer clones recognize specific soluble HLA class I molecules 6
SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int J Cancer 6
Inhibition of human NK cell-mediated killing by CD1 molecules 6
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo 6
Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection 5
Microfluidic biofunctionalisation protocols to form multi-valent interactions for cell rolling and phenotype modification investigations 5
The social life of NK cells 5
LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients 4
Microfluidic devices modulate tumor cell line susceptibility to NK cell recognition. 4
New avenues for melanoma immunotherapy: Natural Killer cells? 1
Totale 903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 3 2 0 0 2 1 1 8 23
2020/202193 18 0 2 0 3 0 2 0 52 16 0 0
2021/2022111 1 0 2 24 4 1 4 35 10 7 22 1
2022/2023472 116 12 17 46 60 46 0 35 74 27 35 4
2023/2024187 40 26 16 15 18 56 6 4 1 5 0 0
Totale 903